- Home
- CMND vs AEON Comparison
CMND vs AEON Comparison
Compare CMND & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMND
- AEON
- Stock Information
- Founded
- CMND 2017
- AEON N/A
- Country
- CMND Canada
- AEON United States
- Employees
- CMND N/A
- AEON N/A
- Industry
- CMND Biotechnology: Pharmaceutical Preparations
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- CMND Health Care
- AEON Health Care
- Exchange
- CMND Nasdaq
- AEON Nasdaq
- Market Cap
- CMND 5.2M
- AEON 4.2M
- IPO Year
- CMND N/A
- AEON N/A
- Fundamental
- Price
- CMND $0.99
- AEON $0.50
- Analyst Decision
- CMND
- AEON Strong Buy
- Analyst Count
- CMND 0
- AEON 1
- Target Price
- CMND N/A
- AEON $360.00
- AVG Volume (30 Days)
- CMND 87.7K
- AEON 299.6K
- Earning Date
- CMND 06-12-2025
- AEON 05-14-2025
- Dividend Yield
- CMND N/A
- AEON N/A
- EPS Growth
- CMND N/A
- AEON N/A
- EPS
- CMND N/A
- AEON 73.23
- Revenue
- CMND N/A
- AEON N/A
- Revenue This Year
- CMND N/A
- AEON N/A
- Revenue Next Year
- CMND N/A
- AEON N/A
- P/E Ratio
- CMND N/A
- AEON $0.01
- Revenue Growth
- CMND N/A
- AEON N/A
- 52 Week Low
- CMND $0.85
- AEON $0.38
- 52 Week High
- CMND $2.30
- AEON $269.28
- Technical
- Relative Strength Index (RSI)
- CMND 47.58
- AEON 36.32
- Support Level
- CMND $0.94
- AEON $0.47
- Resistance Level
- CMND $1.05
- AEON $0.52
- Average True Range (ATR)
- CMND 0.06
- AEON 0.04
- MACD
- CMND 0.00
- AEON 0.07
- Stochastic Oscillator
- CMND 38.22
- AEON 61.93
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.